nipradilol has been researched along with Chronic Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anttila, V; del Nido, P; Suematsu, Y; Takamoto, S | 1 |
| Hikita, H; Kurita, A; Mitani, H; Mizuno, K; Nakamura, H; Nishioka, T; Satomura, K; Takase, B; Uehata, A | 1 |
2 other study(ies) available for nipradilol and Chronic Disease
| Article | Year |
|---|---|
Cardioprotection afforded by ischemic preconditioning interferes with chronic beta-blocker treatment.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Chronic Disease; Contraindications; Heart Ventricles; Ischemic Preconditioning; Lipid Peroxidation; Male; Myocardial Ischemia; Myocardial Reperfusion; Nitric Oxide; Propanolamines; Propranolol; Random Allocation; Rats; Rats, Wistar; Safety | 2004 |
Effect of nipradilol on silent myocardial ischemia, plasma beta-endorphin, and bradykinin in chronic stable angina.
Topics: Adrenergic alpha-Antagonists; Aged; beta-Endorphin; Bradykinin; Chronic Disease; Electrocardiography, Ambulatory; Exercise Test; Heart Rate; Humans; Male; Middle Aged; Myocardial Ischemia; Propanolamines; Radioimmunoassay | 1996 |